Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis

Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis

Item
http://www.wikidata.org/entity/Q37157311
Bryostatin-1 Restores Blood Brain Barrier Integrity following Blast-Induced Traumatic Brain InjuryCD4+NKG2D+ T cells exhibit enhanced migratory and encephalitogenic properties in neuroinflammation.An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.Protein kinase C β inhibition by enzastaurin leads to mitotic missegregation and preferential cytotoxicity toward colorectal cancer cells with chromosomal instability (CIN)Current status and future directions of anti-angiogenic therapy for gliomasN-Butylphthalide Alleviates Blood-Brain Barrier Impairment in Rats Exposed to Carbon Monoxide.Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis.Recent insights into endothelial control of leukocyte extravasation.Barrier function in the peripheral and central nervous system-a review.IL-17-triggered downregulation of miR-497 results in high HIF-1α expression and consequent IL-1β and IL-6 production by astrocytes in EAE mice.Human ESC-derived MSCs outperform bone marrow MSCs in the treatment of an EAE model of multiple sclerosis.ApoE-deficient promotes blood-brain barrier disruption in experimental autoimmune encephalomyelitis via alteration of MMP-9.Blood-brain barrier breakdown promotes macrophage infiltration and cognitive impairment in leptin receptor-deficient mice.Marine-derived protein kinase inhibitors for neuroinflammatory diseases.Protease activated receptor-1 antagonist ameliorates the clinical symptoms of experimental autoimmune encephalomyelitis via inhibiting breakdown of blood-brain barrier.The PKC-β selective inhibitor, Enzastaurin, impairs memory in middle-aged rats.
P2860

Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis

Item
http://www.wikidata.org/entity/Q37157311
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Protein kinase Cβ as a therape ...... l autoimmune encephalomyelitis
@en
Protein kinase Cβ as a therape ...... autoimmune encephalomyelitis.
@nl
type
label
Protein kinase Cβ as a therape ...... l autoimmune encephalomyelitis
@en
Protein kinase Cβ as a therape ...... autoimmune encephalomyelitis.
@nl
prefLabel
Protein kinase Cβ as a therape ...... l autoimmune encephalomyelitis
@en
Protein kinase Cβ as a therape ...... autoimmune encephalomyelitis.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Protein kinase Cβ as a therape ...... l autoimmune encephalomyelitis
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932